Evaluation strategy to determine reliable demyelination in the cuprizone model

Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

Claudia F. Lucchinetti, Wolfgang Br�ck, Joseph E. Parisi et al. · Annals of Neurology · 2000 · 3.3K citations

Life Sciences, Neurology, Pathology +17

Remyelination is extensive in a subset of multiple sclerosis patients

Peter Patrikios, Christine Stadelmann, Alexandra Kutzelnigg et al. · Brain · 2006 · 799 citations · Full text

Life Sciences, Neurology, Neuroscience +10

Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions

John W. Prineas, Rita Barnard, Eunice E. Kwon et al. · Annals of Neurology · 1993 · 573 citations

Medicine, Neurology, Pathology +17

Quantifying the Early Stages of Remyelination Following Cuprizone‐induced Demyelination

Mark F. Stidworthy, Stéphane Genoud, Ueli Suter et al. · Brain Pathology · 2003 · 224 citations · Full text

Medicine, Neurobiology, Neuroscience +16

The sphingosine 1‐phosphate receptor agonist <scp>FTY</scp>720 is neuroprotective after cuprizone‐induced <scp>CNS</scp> demyelination

Alexander Slowik, Thorsten Schmidt, Cordian Beyer et al. · British Journal of Pharmacology · 2014 · 91 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17